Shares of a company Quantum Computing from the quantum computing and computer science sector are up 36% today after the firm beat net income expectations and reported a significant increase in cash on its balance sheet, effectively buying itself more time to reach full and stable profitability.
- Earnings per share came in at 11 cents, beating the consensus estimate of a 7-cent loss.
- Revenue totaled $39,000, below expectations ($100,000), but representing a 44.44% year-over-year increase.
- Cash and cash equivalents at the end of the quarter stood at $166.4 million, a $87.5 million YoY increase.
- Total assets amounted to $242.5 million.
- The company announced significant operational and financial progress in the first quarter.
- It completed construction of its Quantum Photonic Chip Foundry in Tempe, Arizona.
- The facility is intended to meet growing demand for thin-film lithium niobate (TFLN) photonic chips, with the company announcing its fifth order during the period.
QUBT.US shares are still down 50% from their Q4 2024 highs, when the entire quantum sector surged following Google’s comments.
Source: xStation5
MicroStrategy in trouble? Shares down 67% from the highs ✂
Stock of the Week – NVIDIA (21.11.2025)
DE40: European tech and defence stocks sell-off
Morning wrap (21.11.2025)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
